Morbidity and mortality of hospitalized hip fractures in chronic hemodialysis

Abstract EN

Abnormal bone architecture contributes to high incidence of hip fractures in chronic hemodialysis (HD) patients.

Their clinical epidemiology is incompletely described.

We conducted a retrospective cohort study to assess the implications of hospitalization with hip fracture in HD patients compared to the nonchronic kidney disease population.

Thirty-three chronic HD patients admitted with hip fracture over five years were age- and sex-matched on a 1:1 ratio with controls that had hip fracture and normal renal function.

Demographic characteristics, deaths, and readmissions at six months, hospitalization length, time to operation, and laboratory results were recorded from electronic health files.

Data were compared between the two groups using paired t-test for continuous variables and McNemar’s test for categorical variables.

The composite end point of death and/or readmission at 6 months was higher in HD patients (12.1% vs.

6.2%, P <0.001).

Furthermore, mean time to operation was more delayed due to comorbidities (4.7 vs.

2.9 days, P = 0.04).

HD patients had anemia more frequently at presentation (hemoglobin below 10 mg/dL, 32.1% vs.

12.5%, P = 0.003).

Finally, they were more likely to be considered too frail for surgery and not be operated (21.2% vs.

6.2%, P <0.001).

Hip fractures are associated with increased morbidity and mortality and represent an important healthcare burden for chronic HD patients.

Future research is needed to identify definite predictors of adverse outcomes and to implement prevention strategies